The Pix/Cool proteins are involved in the regulation of cell morphology by binding to small Rho GTPases and kinases of the Pak family. Recently, it has been shown that bPix/Cool-1 associates with the ubiquitin ligase Cbl, which appears to be a critical step in Cdc42-mediated inhibition of epidermal-growth-factor-receptor (EGFR) ubiquitylation and downregulation. Here we show that the SH3 domain of bPix specifically interacts with a prolinearginine motif (PxxxPR) present within the ubiquitin ligase Cbl and Pak1 kinase. Owing to targeting of the same sequence, Cbl and Pak1 compete for binding to bPix. In this complex, Cbl mediates ubiquitylation and subsequent degradation of bPix. Our findings reveal a double feedback loop in which the Cdc42/bPix complex blocks Cbl's ability to downregulate EGFR, while Cbl in turn promotes degradation of bPix in order to escape this inhibition. Such a relationship provides a mechanism to fine-tune the kinetics of RTK endocytosis and degradation depending on the pool of active Cdc42 and the duration of EGFR signaling.
Regulation of receptor tyrosine kinases (RTKs) is a major control mechanism of cellular signaling. Ligandactivated RTKs are silenced by receptor internalization followed by endosomal trafficking and subsequent degradation or recycling (Waterman and Yarden, 2001; Dikic and Giordano, 2003) . The E3 ligase Cbl plays a crucial role in these events as it dually participates in early events of internalization via a CIN85-endophilin dependent mechanism (Petrelli et al., 2002; Soubeyran et al., 2002) and endocytic sorting by mediating multiple monoubiquitylation of the receptor Mosesson et al., 2003) . Regulation of Cbl directly affects downregulation of RTKs and thereby influences cellular homeostasis. Most recently, Sprouty2 (Hall et al., 2003; Rubin et al., 2003) , Sts-1/Sts-2 (Carpino et al., 2004; Feshchenko et al., 2004; Kowanetz et al., 2004) as well as bPix (Wu et al., 2003) have been described as negative regulators of Cbl. In either case, molecules act via distinct mechanisms to inhibit Cbl-mediated downregulation of RTKs, eventually resulting in sustained receptor signaling and alterations in cell responses including cell differentiation or transformation.
This work focuses on bPix, (Pak-interacting exchange factor beta) (Manser et al., 1998 ) also known as Cool-1 (cloned out of library 1) (Bagrodia et al., 1998) , which has been described to be involved in cytoskeletal rearrangements and receptor regulation. bPix/Cool-1 has a molecular weight of approximately 85 kD and is modularly assembled with a central Src homology 3 (SH3) domain. Functionally, Pix proteins were believed to be guanine nucleotide exchange factors (GEFs) of the small GTPases Cdc42 and Rac1, which regulate the actin cytoskeleton and, therefore, cell shape and motility (Manser et al., 1998) . However, owing to the modular assembly and the weak GEF activity caused by a unique 18-amino-acid sequence (T1) downstream of its PH domain, bPix resembles a classical adaptor molecule more (Feng et al., 2002) . The atypical SH3-binding sequence described as common Pix-binding motif in Pak proteins (Manser et al., 1998) harbors a proline-arginine motif recognized by SH3 domains of the adaptor molecules CIN85 and CD2AP (Kowanetz et al., 2003) . CIN85/SETA/Ruk and its close relative CD2AP/CMS exist in different isoforms with the longest variant carrying three SH3 domains, a prolinerich domain and a coiled-coil (Dikic, 2002) . A major CIN85 function arises from binding to and clustering of the E3 ubiquitin ligases Cbl/Cbl-b and their involvement in negative receptor regulation Kowanetz et al., 2003) . Most recently, it has been shown that bPix binds to Cbl/Cbl-b and sequesters Cbl proteins from the epidermal growth factor receptor (EGFR), thereby negatively regulating receptor ubiquitylation and downregulation (Wu et al., 2003) . The present work intends to study the fine-tuning of this process dependent on Cbl's association with CIN85 or bPix.
SH3 domain of bPix binds to the proline-arginine motif PKPFPR in Cbl
Recent findings demonstrated that bPix/Cool-1 binds the CIN85 effectors Cbl/Cbl-b (Flanders et al., 2003; Wu et al., 2003) and thereby negatively regulates functions of Cbl proteins. The SH3 domains of Pix proteins have been found to be essential for the interaction with Cbl, but an exact binding site has not been mapped (Flanders et al., 2003) . Phylogenetic analysis of different SH3 domains revealed a close relationship between CIN85 and Pix SH3 domains ( Figure 1a) . Interestingly enough, an atypical prolinearginine motif PxxxPR recognized by the SH3 domains of the adaptor proteins CIN85 and CD2AP (Kowanetz et al., 2003) is part of the bPix target sequence in Pak proteins (Manser et al., 1998) , allowing potentially competitive binding of bPix to Cbl and Pak1. In accordance, initial attempts to detect endogenous interaction of bPix and Cbl revealed co-precipitation of Cbl and bPix in the breast cancer cell lines MCF7 and ZR75 ( Figure 1b ) in co-immunoprecipitation studies. Subsequent pull-down experiments of myc-tagged bPix by diverse HA-tagged Cbl constructs in transiently transfected HEK293T cells identified the motif PKPFPR within Cbl as essential for the association with bPix ( Figure 1c) . Moreover, Cbl-b (also containing the motif) was able to bind bPix (not shown). In order to confirm the hypothesis that PKPFPR mediates the Cbl-bPix interaction, a mutant with a defect in the essential arginine within the motif (Cbl R829A) was analysed in GST pull-downs. This mutation abolished the interaction of Cbl with CIN85 (Kowanetz et al., 2003) as well as with bPix ( Figure 1d) . A different mutant (Cbl 306E) with an intact PKPFPR motif was not affected in its ability to bind to the bPix SH3 domain.
Pak1 and Cbl compete for bPix/CIN85 binding These observations raised the possibility that bPix and CIN85 competitively bind to similar motifs in Cbl/Cbl-b and Pak1. Initially, we analysed whether CIN85 binds Pak1 in mammalian cells. In co-immunoprecipitation studies in HEK293T cells both proteins associated (Figure 2a ). No interaction with the Pak1 R193A mutant could be detected, where the essential arginine within the PxxxPR motif had been mutated. Possibly, Cbl and Pak1 were not directly linked (Figure 2b ), but Cbl efficiently competed CIN85 away from Pak1 (Figure 2c ), whereas Pak1 sequestered Cbl from bPix Figure 1 (a) Phylogenetic analysis (PhyloDraw V0.82) revealed a strong similarity between SH3 domains of bPix and CIN85 (see boxes). (b) Interaction of endogenous Cbl and bPix was detected in cell lysates from breast cancer cell lines MCF7 and ZR75 after immunoprecipitation with Cbl antibodies and detection of coprecipitated bPix by immunoblotting. IP with anti-GST antibody served as an internal control. (c) Further co-immunoprecipitation studies and GST pull-downs revealed binding of bPix SH3 domain to the proline-arginine motif PKPFPR in Cbl, which is also recognized by the adaptor protein CIN85. HEK293T cells transiently transfected with bPix and different HA-tagged Cbl constructs using Lipofectamine (Invitrogen) following the manufacturer's guidelines were lysed in ice-cold Triton X-100 lysis buffer 48 h after transfection and cleared by centrifugation as described . For co-immunoprecipitation studies, lysates were incubated with antibody for 2 h at 41C. Proteinantibody complexes were collected by incubation with protein A-agarose (Roche) for another 2 h followed by centrifugation. Samples were boiled in loading buffer at 951C for 5 min and resolved by SDS-PAGE, subsequently blotted on 0.45 mm nitrocellulose membranes and probed with HA antibody (Santa Cruz). Antibody-complexes were detected using horseradish peroxidaseconjugated secondary antibodies and ECL substrate (Santa Cruz). For GST pull-downs, lysates with adjusted protein concentrations (Bradford assay, BioRad) were incubated with equal amount of GST-bPix SH3 proteins coupled to glutathione beads and incubated for 2 h at 41C. Beads were precipitated, vigorously washed for three times, boiled in sample buffer and analysed by Western blotting. (d) GST pull-downs of GST-bPix-SH3 with Cbl or mutants unraveled the significance of the proline-arginine motif PxxxPR for Cbl-bPix binding. Cbl R829A that is unable to bind CIN85, did not associate with bPix either.
Degradation of bPix by Cbl
MHH Schmidt et al ( Figure 2d ). These data show that CIN85 and bPix competitively associate with Cbl and Pak1 in mammalian cells. Additionally, when Cbl and CIN85 were transiently co-expressed with increasing amounts of bPix protein in HEK293T cells, bPix effectively sequestered CIN85 from Cbl as shown in co-immunoprecipitation experiments with either Cbl or CIN85 antibody ( Figure 2e ). This potentially contributes to bPix' ability to inhibit Cbl/CIN85-mediated receptor endocytosis and degradation.
Cbl mediates degradation of bPix in response to EGF stimulation Direct comparison of bPix binding to Cbl or Cbl R829A mutant in immunoprecipitation studies verified the significance of the PKPFPR motif for their interaction in mammalian cells (Figure 3a and b) . Interestingly, overexpression of Cbl decreased the level of total and Cbl-associated bPix subsequent to EGF stimulation, effects not seen with Cbl R829A (Figure 3a and b, lanes 3 and 4, respectively). When studied in the time course of EGF stimulation experiments, bPix levels decreased upon EGF stimulation (Figure 3c ). Possibly, bPix was targeted for proteasomal degradation upon EGF treatment, thus the experiments were repeated with an additional 6 h of incubation using the proteasome inhibitor MG132 (20 mM) prior to EGF stimulation ( Figure 3d ). bPix levels were stabilized under these conditions and an increased association of Cbl and bPix was observed after 5 min. Please note that also the level of endogenous bPix was stabilized under this condition. Results of Figure 3c and d indicated increased association of both proteins subsequent to EGF treatment, but rapid degradation of the complex afterwards. Furthermore, bPix was found to be phosphorylated upon co-expression with Cbl and EGF treatment (Figure 3e ). Most interestingly, phosphorylation of bPix has been described to lead to a dissociation of the Pix-Pak complex from the plasma membrane and subsequent endocytic sorting (Shin et al., 2002) , which could explain why bPix levels declined in the former experiments. In order to further analyse this observation, HEK293T cells were transfected with bPix and Flagtagged ubiquitin (Ub) and after 48 h degradation was blocked for 6 h using 20 mM MG132, 10 mM lactacystin, 10 mM NH 4 Cl and 50 mM chloroquine. Subsequent were transiently co-expressed in HEK293T cells together with increasing amounts of bPix protein, decreased binding of Cbl and CIN85 was observed by co-immunoprecipitation with either Cbl or CIN85 antibodies, demonstrating competition between bPix and CIN85 under certain conditions. In co-immunoprecipitation studies and immunoblots Pak1, HA and bPix antibodies from Santa Cruz as well as polyclonal anti-Cbl and anti-CIN85 antibodies were used as described .
immunoprecipitation and immunoblotting analyses revealed an approximate 2.5-fold increase in bPix ubiquitylation upon expression of Cbl (Figure 3f ). Degradation of bPix was accompanied by an increased ubiquitylation of the molecule upon Cbl expression, potentially targeting the protein for proteasomal degradation, which strengthens the former point. Furthermore, the data offer the possibility that bPix is sorted towards lysosomal degradation as most of the ubiquitylated bPix pool is found in a monoubiquitylated form. Typically, monoubiquitylated proteins undergo lysosomal degradation and therefore NH 4 Cl and chloroquine had been applied in this experiment.
Cdc42 increases bPix degradation
Previous reports suggest a close relationship between Cbl and Cdc42, which is mediated by bPix (Flanders et al., 2003; Wu et al., 2003) . Indeed, Cdc42 seems to be an important regulator of Cbl functions. In the presence of Cbl, we detected a strong increase in bPix degradation subsequent to Cdc42 transfection (Figure 4a ). No increase in degradation was observed upon Rac1 expression, indicating a Cdc42-specific effect. Interestingly, overexpression of bPix and Pak1 together, protected both proteins from degradation, which is probably because of the competition of Pak1 and Cbl for the same binding motif in bPix under overexpression conditions. This finding offered a double feedback loop in which Cdc42 inhibits Cbl functions (Wu et al., 2003) but Cbl is able to restore its own activity by targeting the linker between both proteins, bPix, for degradation. When HEK293T cells were transiently transfected with increasing amounts of Cdc42, a decrease in the level of endogenous bPix was observed (Figure 4b ). This was also seen with increasing amounts of Cbl but not as strong as compared to Cdc42. As a control the mutant Cbl R829A, unable to bind to bPix, failed to promote the degradation of bPix (Figure 4b ). Pulse-chase experiments further quantified the former observations effect (Figure 4c ). Just as in Figure 4b , it was found that co-expression of Cdc42 and Cbl caused a decrease in the amount of bPix, with Cdc42 being a more potent mediator. However, dependent on the conditions, EGF also had a profound effect on bPix levels as it had already been shown in Figure 3a -c on the immunoblots level. Observing this strong effect on bPix itself, we wondered about the fate of its associated proteins. Interestingly, co-expression of Cdc42 and Cbl, without further overexpression of bPix, decreased the levels of Pak1 (Figure 4d ). Because the latter most likely does not bind Cbl directly (Figure 2b ), the effect was probably mediated by endogenous bPix. Again the effect was specific for Cdc42, as Rac1 had again no effect. This decrease in protein level also affected the pool of activated Pak1 as measured by a myelin basic protein assay (Figure 4e) . Although it is known that bPix has only little effect as a GEF (Feng et al., 2002) , its activity is probably enhanced by aPix owing to formation of heterodimers via leucine zippers near its C terminus (Feng et al., 2004) as shown by yeast two-hybrid screens (Rosenberger et al., 2003) .
This data led us to the conclusion that eventually downregulation of bPix releases Cbl from its inhibitor. This possibility was tested in EGFR downregulation assays in CHO cells (Figure 4f ). Cbl increased EGFR downregulation (compare empty circles to solid diamonds), an effect inhibited by co-expression of bPix (empty quadrates). However, subsequent to the additional co-expression of Cdc42 (empty triangles), bPix gets degraded and looses its inhibitory potential towards Cbl. Cdc42 (solid triangles) or bPix (solid quadrates) alone had only minor effects on EGFR levels in this assay but pointed towards the same direction as under conditions where Cbl was co-overexpressed. There the detected effects were much clearer, which indicates that endogenous Cbl was affected by Cdc42 or bPix, respectively. A Cbl mutant not able to bind to bPix (Cbl R829A) was also not affected by the co-expression of bPix (gray quadrates and triangles). Furthermore, the stabilizing effect of bPix onto the EGFR with or without co-expression of Cdc42 was clearly lost over longer incubation times with EGF, which reflects the time course of EGF-dependent degradation of bPix (Figure 3c) . In order to analyse the physiological relevance of the current findings, RNAi-mediated knock-down of endogenous bPix has been performed (Figure 4g) . Clearly, the downregulation rate of membrane-resident EGFR increases after siRNA-mediated knock-down of endogenous bPix, mainly, during the early phase of endocytosis. This demonstrates that bPix has an inhibitory effect on EGFR downregulation and its removal increases the receptor turnover rate. The effect can still be seen upon overexpression of Cbl, implicating that bPix affects Cbl as already suggested by the data above. Naturally, the effect is much smaller under these conditions, as the endogenous bPix pool has already been occupied by a plethora of Cbl molecules. Consequently, further knock-down of bPix does not significantly increase Cbl-mediated downregulation of the EGFR because it is likely already at maximum speed. However, a small difference can still be detected. The current data offer the possibility of a double feedback loop with Cbl regulating its own inhibitor (Figure 4h ). According to this model, the activated EGFR complex recruits Cbl, which in turn attracts the bPix-Pak1-Cdc42 complex. Subsequently, bPix sequesters Cbl from the receptor and inhibits Cbl-mediated receptor downregulation. However, Cbl now turns towards bPix and ubiquitylates the molecule, which is thereby targeted towards degradation. Consequently, Cbl is free to return to the EGFR and to regulate the receptor complex once again.
In this work, we demonstrate that the prolinearginine motif PxxxPR within Cbl ubiquitin ligases is recognized by bPix and is pivotal for the interaction of both proteins. Initially, the binding sequence of Pix' SH3 domains within mammalian Pak proteins was narrowed down to PPxxxPRxxTxSxYT (Manser et al., 1998) . This sequence harbors the CIN85-binding site PxxxPR and our data indicate that bPix and CIN85 competitively bind the same sites in Cbl and Pak proteins. So far, the CIN85/CMS-family of adaptor molecules consists of CIN85/SETA/Ruk and CD2AP/ CMS (Dikic and Giordano, 2003) but in the light of these findings, bPix is a functionally related SH3-domain-containing adaptor protein, recognizing the same proline-arginine motif. This has been verified by the crystal structure of CIN85 and bPix SH3 domains with Cbl peptides that has recently been solved (Jozic et al., 2005) . Interestingly, Cbl-peptides induce formation of heterotrimeric complexes consisting of two SH3 domains and one peptide molecule, which depends on two crucial arginine molecules within the Cbl-peptide, Arg904 and Arg911. Loss of the former arginine, resembling the situation in for example Pak1, changes the binding stoichiometry of SH3 domain and peptide to 1:1. This explains, why CIN85 and bPix bind Cbl and Pak1 differently, despite both proteins sharing the same PXXXPR motif.
These results are interesting in light of increased association of Cdc42, bPix and Cbl upon EGF stimulation, which was proposed to drive Cbl away from the EGFR (Wu et al., 2003) . This regulation mechanism of Cbl, together with others, has been discussed in more detail elsewhere . In that way, Cdc42 negatively interferes with EGFR ubiquitylation and downregulation and may contribute to transformation of cultured fibroblasts by oncogenic forms of Cdc42 (Wu et al., 2003) . However, the exact mechanism of how bPix sequesters Cbl away from the EGFR has not yet been unraveled. The very fact that bPix and CIN85 recognize the same motif in Cbl implies a mutually exclusive mode of action of these adaptors at the level of Cbl. We propose a model, where Cbl gets activated by ligand stimulation of EGFR, which in turn leads to a conformational change in the molecule that exposes the C-terminal proline-arginine motif. At the points of cross talk between RTK and endocytosis, high concentrations of active Cdc42 and bPix may promote binding of bPix to Cbl, pushing out the usually preferred binding partner CIN85 from the Cbl complex. This competitive mechanism could block the CIN85-imposed clustering phenomenon on Cbl that is required for tighter binding of Cbl to activated receptors as well as EGFR endocytosis (Kowanetz et al., 2003) . Current findings provide additional support for the more general role of targeting binding sites of CIN85 SH3 domains (Haglund et al., 2005) . It is shown that dual binding of Sprouty2 to Cbl as well as to the SH3 domains of CIN85 is mandatory for Sprouty2 to inhibit downregulation of the EGFR. Sprouty2 contains two binding motifs for CIN85 SH3 domains A and C, thus allowing binding of only one SH3 domain of CIN85 to a single Cbl molecule, while bPix directly competes with CIN85 for binding to Cbl thus completely dissociating the Cbl/CIN85 axis. Equally, a direct consequence is the uncoupling of the EGFR from CIN85-mediated endocytic sorting. An indirect consequence is the sequestration of Cbl from the EGFR complex, which eventually causes decreased receptor ubiquitylation.
It is also likely that Cbl inhibitors underlie a double feedback regulation by Cbl as demonstrated here for Cbl-induced degradation of bPix (Figure 3a and b) and previously for Sprouty2 (Rubin et al., 2003) . One possibility is that binding of Cdc42 to bPix exposes ubiquitin moieties, whose transfer had been mediated by Cbl, which together with increased phosphorylation targets the bPix complex for degradation. The resulting loss of Cdc42's linker to Cbl implicates a double feedback loop, in which Cbl escapes its inhibitor in order to reconstitute its own activity. Eventually, Cbl is free to bind to the EGFR or to be blocked by Cdc42/ bPix again, depending on the pool of accessible bPix, active Cdc42 and the duration of receptor signaling.
Taken together, these results support a novel scenario whereby inhibitors of Cbl commonly target the Cbl/ CIN85 binding interface in order to sequester Cbl and block EGFR ubiquitylation and early phases of clathrin-mediated endocytosis. Exploring the parameters underlying inhibition of Cbl functions in vivo is of utmost importance for our understanding of the kinetics of EGFR endocytosis and receptor deregulation in cancer.
